Information  X 
Enter a valid email address

Verici Dx Plc Ord GBP0.001 (VRCI)

Date Time Source Announcement
27 Jun 2022 3:17 pm
RNS
Result of AGM and voting results
24 Jun 2022 7:00 am
RNS
Holding(s) in Company
20 Jun 2022 7:30 am
RNS
Distribution of Verici Dx shares by EKF
16 Jun 2022 7:00 am
RNS
Investor Presentation
15 Jun 2022 10:57 am
RNS
CEO Video Interview
14 Jun 2022 9:00 am
RNS
Further data from TutevaT validation study
09 Jun 2022 7:00 am
RNS
Commercial Team Appointments
25 May 2022 12:00 pm
RNS
Posting of Annual Report & Accounts
19 May 2022 7:00 am
RNS
Final Results
12 May 2022 7:00 am
RNS
Results of TutevaT clinical validation study
01 Apr 2022 7:00 am
RNS
Clinical Validation Study Update
23 Mar 2022 6:12 pm
RNS
Holding(s) in Company
21 Mar 2022 7:00 am
RNS
Holding(s) in Company
18 Mar 2022 5:13 pm
RNS
Holding(s) in Company
16 Mar 2022 3:33 pm
RNS
Holding(s) in Company
15 Mar 2022 4:34 pm
RNS
Holding(s) in Company
11 Mar 2022 9:30 am
RNS
Close of Subscription and Fundraise Update
04 Mar 2022 4:13 pm
RNS
Result of Fundraise
  12:20 pm
RNS
Close of Accelerated Bookbuild
  7:10 am
RNS
Proposed Fundraise
15 Feb 2022 7:00 am
RNS
Successful completion of analytical validation
14 Jan 2022 7:00 am
RNS
Investor Presentation
12 Jan 2022 2:00 pm
RNS
Progress and strategy update
06 Jan 2022 7:00 am
RNS
ClaravaT and TutevaT complete testing requirements
05 Jan 2022 7:00 am
RNS
Collaboration with Illumina
04 Jan 2022 7:00 am
RNS
Grant of two CPT Codes by AMA
17 Dec 2021 1:19 pm
RNS
Holding(s) in Company
08 Nov 2021 7:00 am
RNS
Launch of Barbara T. Murphy Endowed Lectureship
01 Nov 2021 7:00 am
RNS
Launch of Career Development Research Grant
13 Sep 2021 7:01 am
RNS
Lorenzo Gallon, MD, Appointed as Chair of S.A.B
  7:00 am
RNS
Half-year Report
06 Sep 2021 7:00 am
RNS
Notice of Results
31 Aug 2021 7:00 am
RNS
Patient enrolment completed
19 Aug 2021 7:00 am
RNS
Appointment of Non-executive Director
27 Jul 2021 7:00 am
RNS
Acceptance to CLIA Program
20 Jul 2021 7:00 am
RNS
First European Clinical Trial Site Initiated
01 Jul 2021 4:56 pm
RNS
Directorate Change
24 Jun 2021 7:00 am
RNS
Non-executive Director receives award
26 May 2021 4:41 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
19 May 2021 3:14 pm
RNS
Result of AGM
05 May 2021 7:00 am
RNS
Notice of Change of AGM Venue
29 Apr 2021 7:00 am
RNS
Lease signed for laboratory
14 Apr 2021 7:01 am
RNS
MTA secured to assess CTOT-19 samples
  7:00 am
RNS
Final Results
13 Apr 2021 2:06 pm
RNS
Second Price Monitoring Extn
  2:01 pm
RNS
Price Monitoring Extension
  11:05 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
17 Mar 2021 7:00 am
RNS
Notice of Results
02 Mar 2021 7:00 am
RNS
First clinical trial sites initiated in US
09 Feb 2021 7:00 am
RNS
Capital Markets Day for Kidney Health
08 Feb 2021 7:00 am
RNS
Accelerated CLIA approval strategy
05 Feb 2021 4:41 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
18 Jan 2021 2:06 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
  11:05 am
RNS
Second Price Monitoring Extn
  11:01 am
RNS
Price Monitoring Extension

a d v e r t i s e m e n t